Anthropic IPO: How to Invest in Claude Before, During, and After Its Stock Market Debut

Several stock brokers, including Trade Republic, Interactive Brokers and Revolut, allow participation in the IPO by requesting shares at the issue price. Other trading platforms already offer solutions to speculate on Anthropic before its Nasdaq arrival, notably through CFDs, tokenized shares, or leveraged ETPs.

What are the different options to position oneself on the Anthropic IPO? How to proceed concretely and what risks should you know? Café de la Bourse reviews the solutions accessible to individual investors to invest in Claude.

Anthropic IPO: what are the dates and key information to know?

The Anthropic IPO is scheduled for November 19, 2026 on the Nasdaq, under the symbol ANT. The company behind Claude plans to offer 825 million shares, with an indicative price range between $70 and $78 per Anthropic share.

The offering could thus raise up to $64.35 billion, excluding private placement. For investors who wish to participate in the IPO, the timeline is particularly tight: the final price should be set on November 18, 2026, the eve of the first quotations.

Anthropic IPO Technical Data

How to participate in the Anthropic IPO?

Buying a stock on the market and participating in an IPO aren’t exactly the same thing.

In the first case, the investor buys at the market price, which moves with supply and demand.

For an Initial Public Offering, the process is more like an auction: investors indicate how many shares they want to obtain, sometimes with a maximum price.

The banks handling the deal then review the requests, determine the IPO price, and allocate the shares. And when demand is high, there isn’t necessarily enough for all investors.

How to subscribe to the Anthropic IPO?

Good news for retail investors: the top stock brokers allow participation in the Anthropic IPO without waiting for the first ANT trades on Nasdaq.

Among the brokers that allow participation in the Anthropic IPO are notably Trade Republic, Interactive Brokers, eToro, Revolut, MEXEM, DEGIRO or Saxo Bank.

To subscribe to the Anthropic IPO, here are the main steps to follow:

1. Choose a stock broker offering the operation and open a brokerage account if you do not already have one. Check that the offer is accessible from your country of residence.
2. Search for the Anthropic IPO in your client area, usually under “IPO”, “Initial Public Offerings” or “New issues.” The exact location depends on the online broker.
3. Review the subscription conditions, including the indicative price range, any fees, and the deadline to submit your request.
4. Indicate the number of shares you want, or the amount to invest depending on the trading platform. Some stock brokers also allow setting a maximum price. Ensure you have the necessary funds in your brokerage account.
5. Submit your subscription request and wait for the allocation result. The corresponding funds may be temporarily blocked in your account.

Comment by Marc:

Be mindful of the calendar, because if the official closing of the offer is scheduled for November 18, 2026, some stock brokers may stop accepting requests earlier. It’s better not to wait until the last moment.

How to obtain Anthropic shares at the IPO price?

This is probably the main uncertainty for investors: even if you subscribed on time, there is no guarantee you will receive the shares requested. And the more successful an IPO is, the higher the risk of partial, or even zero, allocation.

Let’s take an example. You request 20 Anthropic shares, but demand is five times the number of available shares. If a pro rata allocation is applied, you might receive only 4 ANT shares. In some cases, you might receive nothing.

To maximize your chances, follow a few simple rules:

• Subscribe early, to avoid missing the deadline set by your stock broker.
• Plan the necessary liquidity, so that your request isn’t rejected for insufficient funds.
• Check allocation terms, since rules can vary from one intermediary to another.
• Set a sensible limit price, when available, to avoid a too-restrictive order being rejected if the final IPO price is higher.

There is, however, no magic method to obtain more shares. The lead banks have latitude in allocating shares, and each broker can apply its own rules.

Allocated investors will receive their shares after settlement and delivery, scheduled from November 20, 2026. As for the others, they can still buy the ANT stock on Nasdaq once trading begins, but at a price that could be well higher than the IPO price.

How to speculate on the Anthropic IPO before it debuts on the stock market?

An IPO as highly anticipated as Anthropic’s not only excites investors. It also inspires ideas among stock brokers, crypto platforms, and financial product issuers. Several players have thus developed specific instruments to allow retail investors to speculate on the Anthropic IPO without waiting for its Nasdaq arrival. Pre-IPO CFDs, tokenized shares, perpetual contracts, or leveraged ETPs: the possibilities are numerous, but they do not all work in the same way. And above all, none should be confused with a direct purchase of Anthropic shares!

Speculating on the Anthropic IPO with CFDs

CFDs allow you to position on the rise or fall of an asset without owning it. For the Anthropic IPO, brokers such as XTB or IG offer solutions even before its first listing on Nasdaq:

• XTB offers the pre-IPO CFD ANTH.24H7, whose price is based on over-the-counter quotes prior to the introduction. Investors can thus take a position on the anticipated price movement of Anthropic, without waiting for the ANT share to be tradable on Nasdaq.
• IG has developed a somewhat special pre-IPO market. Here, the trader bets on the market capitalization Anthropic could reach at the close of its first session. They can close their position before the IPO, as long as the market remains tradable, or wait for settlement based on the valuation actually observed.

These instruments are mainly aimed at experienced traders. Leverage can amplify both gains and losses. And before the IPO, displayed prices can deviate significantly from the future official price of the Anthropic share.

*Your capital is at risk. See terms on the site.

Speculating on the Anthropic IPO with tokenized shares

The leading crypto platforms have also positioned themselves around the event. Kraken offers, for example, access to the Anthropic IPO via ANTx, an xStock allowing exposure to the share price movement without directly owning it.

Available from $10, the offer lets eligible users express their interest before the subscription close. The price corresponds to the IPO price, plus a 5% spread. Note that allocation is not guaranteed: it can be full, partial, or none. Unallocated funds are returned.

Other crypto platforms, such as Bybit and OKX, offer a more speculative approach with pre-IPO perpetual contracts on Anthropic. Unlike Kraken’s xStocks, these are not tokenized shares, but derivative products allowing bets on the movement of a reference price, typically with leverage.

These contracts carry significant risks, including rapid liquidation in case of unfavorable movement. Their availability also depends on the investor’s country of residence.

Speculating on the Anthropic IPO with ETPs

There is one last option with leveraged exchange-traded products.

The issuer Leverage Shares has notably launched a 3x Long Anthropic ETP, identified by the ticker ANT3, which aims to triple the daily performance of Anthropic stock after its IPO.

However, be aware of an important nuance: before the IPO, this ETP remains largely invested in cash. Buying the product in advance does not automatically grant you the potential upward movement between the IPO price and the first listed price. Once exposure is activated, the daily leverage can also significantly amplify losses.

In the United States, GraniteShares plans two leveraged ETFs on Anthropic: one to position on the daily upside, the other on the daily downside. These products target the U.S. market and may not be accessible to European retail investors. Other similar instruments could nevertheless emerge in Europe after the IPO.

Should you participate in the Anthropic IPO or wait for the first trading day of ANT on November 19? Café de la Bourse’s View

The Anthropic IPO holds real appeal for investors seeking exposure to the development of artificial intelligence. But a promising company does not automatically make a good investment at any price. With a fully diluted valuation potentially reaching around $1.4 trillion, based on the indicative range of $70 to $78 per ANT share, the market already factors in substantial growth prospects.

Participating in the Anthropic IPO can nevertheless be attractive for a long-term investor, provided they obtain shares at the IPO price and maintain a reasonable exposure. The main advantage is to avoid a potential surge in Anthropic’s stock price during its first trades. In return, there is no guarantee that ANT will rise after its IPO, even if investor demand is very strong.

Our view: we would favor a measured subscription at the IPO price rather than a rushed purchase at the Nasdaq open. If ANT climbs by 30% or 50% in its first session, it’s better to accept missing out on an opportunity than paying a valuation that has become hard to justify. Conversely, a post-IPO correction could offer a more attractive entry point.

For investors wanting to build a long-term position, a gradual entry into Anthropic stock, possibly via dollar-cost averaging (through an investment plan offered by a broker such as Freedom24, Bourse Direct, or ProRealTime x Interactive Brokers for example), seems more appropriate than a large one-time investment. It will be important to monitor Anthropic’s financial results, its ability to fund its infrastructure, and the evolution of its profitability. The commercial success of Claude will not suffice, on its own, to guarantee the performance of Anthropic stock on the market.

The information from Cafedelabourse.com and its publications is provided for educational purposes. It does not constitute investment recommendations. The reader should study the risks before making any transaction. They are solely responsible for their investment decisions.

Past performances do not guarantee future results. Investing in stocks carries the risk of capital loss.

All of our information is, by nature, generic. It does not take into account your personal situation and does not constitute personalized investment advice or an invitation to buy or sell financial instruments. The reader is solely responsible for using the information provided, and no recourse against Cafedelabourse.com’s publisher is possible. The publisher’s liability cannot be engaged in case of error, omission, or inappropriate investment.